Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Anti Viral Agents. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1066658A details efficient asymmetric synthesis of antiviral furanoside intermediates, offering scalable routes for HIV therapeutic manufacturing.
Patent CN1255919A details an efficient enantioselective addition reaction for DMP-266 intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Advanced synthesis of optically active 1-amino-2-vinylcyclopropane carboxylic acid esters via chiral resolution. Reliable pharmaceutical intermediate supplier offering cost-effective antiviral API precursors.
Patent CN107522763B reveals a high-yield route for Sofosbuvir intermediate VII, eliminating chromatography and reducing costs for pharmaceutical manufacturers.
Patent CN1046728C reveals a streamlined process for cyclopropane nucleoside analogs. Discover cost-effective manufacturing and scalable supply chain solutions for high-purity antiviral intermediates.
Patent CN106083745B reveals a mild four-step route for Favipiravir intermediates. Achieve cost reduction in API manufacturing with reliable supply chain solutions.
Patent CN111995607A details a novel aqueous synthesis for phenyl selenized luteolin and quercetin, offering scalable antiviral intermediate production with reduced costs.
Patent CN111995606B reveals a novel aqueous nucleophilic substitution for 7-methyl ketone luteolin and quercetin, offering significant cost reduction and scalable manufacturing.
Patent CN111995608A details a novel C-O coupling method for luteolin-quercetin dimers. Discover cost-effective manufacturing and high-purity antiviral intermediates.
Advanced three-step synthetic route for Sofosbuvir intermediate reduces impurities and enhances supply chain reliability for global pharmaceutical manufacturing partners.
Novel synthesis of brominated and piperazine-ring rupestonic acid esters for antiviral applications. Efficient phase-transfer catalysis route ensures high purity and scalable production for pharmaceutical partners.
Patent CN112266392A discloses a high-purity process for Cenicriviroc mesylate using optimized Suzuki coupling and amide formation, ensuring supply chain stability.
Patent CN114591217A reveals a novel lactone-based route for 6,6-dimethyl-3-azabicyclo[3.1.0]hexane, offering superior atom economy and cost reduction in API manufacturing for antiviral drugs.
Patent CN109295026B reveals a high-efficiency enzymatic route for Zalcitabine. Discover cost-effective biocatalysis solutions for nucleoside analogues manufacturing.
Patent CN103145608B reveals novel caprolactam synthesis for EV71 treatment offering scalable routes and cost reduction in pharmaceutical intermediate manufacturing.
Patent CN107868105A reveals advanced recrystallization for Sofosbuvir intermediates. Achieves 99.8% purity with improved yield for reliable pharmaceutical supply chains.
Patent CN113461631A reveals novel 1,3,4-oxadiazole inhibitors with superior anti-influenza activity. Explore scalable synthesis and supply chain advantages for pharmaceutical manufacturing.
Patent CN107108681B reveals a high-purity nucleoside analog synthesis route eliminating chromatography, offering significant cost and supply chain advantages for pharmaceutical manufacturers.
Patent CN1775791A details a novel route for 2-deoxy-D-glucose from glucosamine. Discover cost-effective manufacturing and high-purity supply chain solutions.
Discover a novel zeolite-catalyzed route for 4-aminopyrrolo[2,1-f][1,2,4]triazine. High yield, scalable process for Remdesivir intermediates with reduced environmental impact.